Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FV5EN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,332
Award facts
- Contract value 100% obligated
- $8,331.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,331.60 to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of Nexplanon 68 mg implants. Nexplanon is a subdermal contraceptive implant used by the Department of Defense healthcare system. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 7, 2025, and will be performed in Park Ridge, Illinois, where the contractor is based. No set-aside designation was applied to this award.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently delivering a comprehensive range of branded and generic prescription drugs, biologics, and medical consumables to military health facilities worldwide. The company's long-standing partnership with the DLA, evident through its extensive portfolio of pharmaceutical product deliveries since SAM.gov registration in 2001, demonstrates its reliability as a preferred vendor for Department of Defense medical supply needs.
Quick answers
Who was awarded contract SPE2DB25FV5EN?
SPE2DB25FV5EN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FV5EN worth?
The government has obligated $8,332 on SPE2DB25FV5EN.
Is contract SPE2DB25FV5EN an order under another contract?
Yes. SPE2DB25FV5EN is a delivery order under SPE2DB22D9206, an indefinite delivery contract.
Was contract SPE2DB25FV5EN competed?
The extent of competition for SPE2DB25FV5EN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award